Hemofiltrate CC Chemokine 1[9-74] Causes Effective Internalization of CCR5 and Is a Potent Inhibitor of R5-Tropic Human Immunodeficiency Virus Type 1 Strains in Primary T Cells and Macrophages
暂无分享,去创建一个
R. Doms | F. Kirchhoff | N. Heveker | J. Münch | R. Stauber | S. Pöhlmann | F. Baribaud | W. Forssmann | S. Escher | K. Adermann | L. Ständker | E. Klüver | O. Rosorius | G. Sass | A. Papkalla
[1] F. Kirchhoff,et al. Natural Proteolytic Processing of Hemofiltrate Cc Chemokine 1 Generates a Potent Cc Chemokine Receptor (Ccr)1 and Ccr5 Agonist with Anti-HIV Properties , 2000, The Journal of experimental medicine.
[2] P. Schulz-Knappe,et al. Posttranslationally processed forms of the human chemokine HCC-1. , 2000, Biochemistry.
[3] E. Arts,et al. Variable Sensitivity of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates to Inhibition by RANTES Analogs , 2000, Journal of virology.
[4] M. Foda,et al. Involvement of both the V2 and V3 Regions of the CCR5-Tropic Human Immunodeficiency Virus Type 1 Envelope in Reduced Sensitivity to Macrophage Inflammatory Protein 1α , 2000, Journal of Virology.
[5] V. Miller,et al. Unexpected coreceptor usage of primary human immunodeficiency virus type 1 isolates from viremic patients under highly active antiretroviral therapy. , 2000, The Journal of infectious diseases.
[6] H. Sticht,et al. Synthesis and characterization of the human CC chemokine HCC-2. , 1999, The journal of peptide research : official journal of the American Peptide Society.
[7] J. Albert,et al. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS. , 1999, Journal of human virology.
[8] H. Schuitemaker,et al. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression. , 1999, The Journal of infectious diseases.
[9] A. Trkola,et al. The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That Enhances Viral Infectivity , 1999, Journal of Virology.
[10] J. Moore,et al. HIV-1 entry inhibitors: Evading the issue , 1999, Nature Medicine.
[11] Pascal Poignard,et al. Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants , 1999, Journal of Virology.
[12] F. Kirchhoff,et al. Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1. , 1999, The Journal of general virology.
[13] H. Guy,et al. Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function* , 1999, The Journal of Biological Chemistry.
[14] R. Doms,et al. Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection. , 1999, Blood.
[15] A. Trkola,et al. Enhancement of Human Immunodeficiency Virus Type 1 Infection by the CC-Chemokine RANTES Is Independent of the Mechanism of Virus-Cell Fusion , 1999, Journal of Virology.
[16] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[17] M. Parmentier,et al. The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state. , 1998, Virology.
[18] M. Parmentier,et al. Synthetic full‐length and truncated RANTES inhibit HIV‐1 infection of primary macrophages , 1998, AIDS (London).
[19] J. Boyd,et al. Identification of C-C Chemokine Receptor 1 (CCR1) as the Monocyte Hemofiltrate C-C Chemokine (HCC)-1 Receptor , 1998, The Journal of experimental medicine.
[20] E. De Clercq,et al. Determinants for Sensitivity of Human Immunodeficiency Virus Coreceptor CXCR4 to the Bicyclam AMD3100 , 1998, Journal of Virology.
[21] N. Tarasova,et al. Spontaneous and Ligand-induced Trafficking of CXC-Chemokine Receptor 4* , 1998, The Journal of Biological Chemistry.
[22] E. Santagostino,et al. Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages. , 1998 .
[23] M. Wainberg,et al. Effect of HIV constructs containing protease‐reverse transcriptase fusion proteins on viral replication , 1998, AIDS.
[24] J. Grivel,et al. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. , 1998, The Journal of clinical investigation.
[25] C. Mackay,et al. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. , 1998, Virology.
[26] M. Mack,et al. Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.
[27] Hassan Mohammad Naif,et al. Cutting Edge: Dichotomous Effects of β-Chemokines on HIV Replication in Monocytes and Monocyte-Derived Macrophages , 1998, The Journal of Immunology.
[28] A. Trkola,et al. Genetic Subtype-Independent Inhibition of Human Immunodeficiency Virus Type 1 Replication by CC and CXC Chemokines , 1998, Journal of Virology.
[29] J. Hoxie,et al. Phorbol Esters and SDF-1 Induce Rapid Endocytosis and Down Modulation of the Chemokine Receptor CXCR4 , 1997, The Journal of cell biology.
[30] C. Mackay,et al. Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding , 1997, The Journal of experimental medicine.
[31] R. Doms,et al. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. , 1997, Virology.
[32] A. Trkola,et al. Co-receptors for HIV-1 entry. , 1997, Current opinion in immunology.
[33] Jean Salamero,et al. HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.
[34] B. Cullen,et al. HIV‐1‐induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR‐5 co‐receptor , 1997, The EMBO journal.
[35] T. Schwartz,et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.
[36] A. Garzino-Demo,et al. The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection , 1996, Nature Medicine.
[37] Marc Parmentier,et al. Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity , 1996, Cell.
[38] M. Baggiolini,et al. HIV blocked by chemokine antagonist , 1996, Nature.
[39] M. Bukrinsky,et al. Chemokines and HIV replication , 1996, Nature.
[40] Steven M. Wolinsky,et al. Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.
[41] M. Raida,et al. HCC-1, a novel chemokine from human plasma , 1996, The Journal of experimental medicine.
[42] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[43] M. Reitz,et al. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 , 1995, Journal of virology.
[44] Mauro Vaccarezza,et al. Role of Lymphoid Organs in the Pathogenesis of Human Immunodeficiency Virus (HIV) Infection , 1994, Immunological reviews.
[45] P. Sharp,et al. A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. , 1993, Virology.
[46] J. Kappes,et al. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes , 1991, Journal of virology.
[47] A. Cann,et al. Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation , 1990, Journal of virology.
[48] H. Vinters,et al. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. , 1987, Science.